Vertex Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 468.09
| VRTX Stock | USD 468.09 4.36 0.94% |
Vertex |
Vertex Pharmaceuticals Target Price Odds to finish over 468.09
The tendency of Vertex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 468.09 | 90 days | 468.09 | about 61.49 |
Based on a normal probability distribution, the odds of Vertex Pharmaceuticals to move above the current price in 90 days from now is about 61.49 (This Vertex Pharmaceuticals probability density function shows the probability of Vertex Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Vertex Pharmaceuticals has a beta of 0.64. This entails as returns on the market go up, Vertex Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vertex Pharmaceuticals will be expected to be much smaller as well. Additionally Vertex Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Vertex Pharmaceuticals Price Density |
| Price |
Predictive Modules for Vertex Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vertex Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vertex Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vertex Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vertex Pharmaceuticals is not an exception. The market had few large corrections towards the Vertex Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vertex Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vertex Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.64 | |
σ | Overall volatility | 14.27 | |
Ir | Information ratio | -0.08 |
Vertex Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vertex Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vertex Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vertex Pharmaceuticals generated a negative expected return over the last 90 days | |
| Over 96.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Why Vertex Pharmaceuticals Outpaced the Stock Market Today |
Vertex Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vertex Stock often depends not only on the future outlook of the current and potential Vertex Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vertex Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 260.5 M | |
| Cash And Short Term Investments | 11.2 B |
Vertex Pharmaceuticals Technical Analysis
Vertex Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Vertex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vertex Pharmaceuticals. In general, you should focus on analyzing Vertex Stock price patterns and their correlations with different microeconomic environments and drivers.
Vertex Pharmaceuticals Predictive Forecast Models
Vertex Pharmaceuticals' time-series forecasting models is one of many Vertex Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vertex Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vertex Pharmaceuticals
Checking the ongoing alerts about Vertex Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vertex Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vertex Pharmaceuticals generated a negative expected return over the last 90 days | |
| Over 96.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Why Vertex Pharmaceuticals Outpaced the Stock Market Today |
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.